Google+ Followers

Saturday, 21 February 2015

Healthcare Stocks: Pass or Fail the Ratio Test? Question from our friend


Thank you Selena for your question:

Adventa, Biosis MGRC : P/E is 0 - Not recommended

Supermax - P/E below 15, I will Monitor/Consider
Topglove - P/E below 15, I will Monitor/Consider
Kossan  - P/E is high. I will Keep in View
Hartalega - P/E is high. I will Keep in View

Faber, KPJ and IHH - P/E is too high, I will Keep in View

YSP & CCM - Good dividend & Good FA, I will Monitor/Consider
APEX, PETERLABS, Pharma - I will Keep in view (I may consider if quarterly earnings improved and with new catalysts)

Hovid - P/E is high but having catalysts - I May Monitor/Consider.

Disclaimer and Declaration
The full content of the article is for educational purposes only and should not be used as investment recommendations. We are not responsible for all investment activities conducted by the participants and cannot be held liable for any investment loss. Examples of specific shares may be citied for
illustration purposes.
Regards,
Humble Pie

2 comments:

  1. Hovid - P/E is high but having catalysts - I May Monitor/Consider.

    How's the recent performance and FA/Qtr Report of Hovid? have you started invest into it?

    ReplyDelete
  2. Dear CS,
    Not yet. market is not favorable.

    ReplyDelete